Short answer: No, not permanently
This article is educational and is not a substitute for a clinical evaluation
Furthermore, in three previous RCTs of non-pregnant hypertensive patients, with and without CVD, we demonstrated that intervention with low-dose riboflavin (16 mg/d) for 16 weeks resulted in a lowering of systolic blood pressure by up to 13 mmHg, specifically in those with the TT genotype (Reference Horigan, McNulty and Ward112Reference Wilson, Mcnulty and Ward114)
The good news is that these side effects typically diminish as the body adjusts, especially when the titration schedule is followed properly
Promotes healthy lipid metabolism
Elevated levels of ROS destroys the physiological functions by cross-linking with lipids, protein, and DNA, which lead to several diseases, including cancer, cardiovascular, diabetes, arthritis, neurological disorders and others metabolic diseases